BioCentury
ARTICLE | Company News

Lonza sales and marketing update

January 2, 2012 8:00 AM UTC

Lonza launched its microbial-based platform to produce plasmid DNA vaccines and therapeutics. Lonza said the platform results in reduced development time, higher product yields, improved purity and sh...